Static Chart Scopus BioPharma Inc.

Equities

Market Closed - OTC Markets Other stock markets 11:06:30 2024-05-20 EDT			5-day change	1st Jan Change
0.0021 ^USD	+90.91%		+90.91%	-95.13%

2023	Scopus BioPharma Inc. Presents DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma	CI
2023	Scopus BioPharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Duration

Period